Researchers sought to evaluate the prevalence of pre-existing conditions for adverse events and potential drug-drug interactions related to selected atypical antipsychotics and other non-antidepressant agents among adults with treatment-resistant depression.
Simple coping behaviors may protect against anxiety and depressive symptoms during the COVID-19 pandemic and lockdown.
Study finds screening methods for teenage girls and adult women are generally accurate for the diagnosis of generalized anxiety disorder.
Researchers conducted a randomized clinical trial to assess whether 24 weeks of treatment with rotigotine can modify cognitive functions in patients with mild to moderate Alzheimer disease.
Heightened cognitive arousal at bedtime is linked to objective sleep disturbances and indicators of psychological hyperarousal at night and during the day.
Healthcare professionals see the benefits of prescribing cannabis therapies but report significant knowledge gaps in both recreational and medical cannabis.
Researchers sought to examine national- and county-level buprenorphine prescription patterns by patient demographics and clinician specialty, and county-level characteristics associated with buprenorphine dispensing.
Researchers sought to determine the relationship between neuroimaging markers and other clinical characteristics with mild parkinsonian signs in older adults.
Approximately one-third of patients with migraine reported using opioids to treat their symptoms, a practice that contrasts with current guidelines.
The American College of Physicians statement outlines how the “status quo” created health inequalities and prevented the spread of the COVID-19 virus, and outlines steps on how to move forward.
